DOHA: The second Arab Diabetes Medical Congress will be held in Doha in November and discuss prevention and control of the disease in the region.
The congress will be organised in collaboration with the Qatar Diabetes Association and Maarefah Management and supported by Rashid Centre for Diabetes and Research, the Saudi Diabetes and Endocrine Association, and Saudi Pharmaceutical Society.
The congress will focus on a number of important issues related to diabetes, through scientific lectures, workshops, panel sessions and share information and strategies for prevention and control of the disease.
Discussions will also include about detection and prevention of Type 2 diabetes, early intervention in children and adult patients, obesity, insulin resistance and type 2 diabetes in children and adolescents, among other important topics in order to control the disease in the region.
Dr Doaa Said, Managing Director, Maarefah Management, said, “Diabetes complications expenditure reaches up to 11 percent of global expenditure on health-care sector, which requires to develop ways to prevent and fight the disease, and to intensify efforts and research to get the appropriate treatment while working to help patients to avoid complications.”
“Arab Diabetes Medical Congress attracts leading international researchers and experts, which contributes to the exchange of ideas and the latest information on complications especially in Middle East,” she added.
Key speakers at the conference include Dr Abdullah Al Hamaq, Executive Director, Qatar Diabetes Association, Dr Mahmoud Zirie, Senior Consultant and Head of Endocrinology, Diabetes and Metabolism Department of Medicine, HMC, Kamil M Salamah, General Secretary, Saudi Diabetes & Endocrine Association, KSA, Moataz Basha, Director of Metabolic & Bariatric Surgery, HMC and Ebaa Al Ozairi, Consultant Endocrinologist, American Board of Physician Nutrition Specalist, Kuwait.
